CASI Pharmaceuticals (CASI) Revenue (2020 - 2025)
CASI Pharmaceuticals (CASI) revenue from Dec 31, 2020 to Dec 31, 2025. The TTM CASI Pharmaceuticals (CASI) revenue is $21M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
CASI Pharmaceuticals (CASI) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -27.44% |
| 3 Years | -18.35% |
| 5 Years | +6.66% |
| All Time | +6.66% |
Annual Revenue change of CASI Pharmaceuticals (CASI)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $21M | -27.44% |
| 2024 | $29M | -15.76% |
| 2023 | $34M | -10.96% |
| 2022 | $38M | +26.75% |
| 2021 | $30M | +100.13% |
| 2020 | $15M | N/A |
Comparison CASI Pharmaceuticals (CASI) five years revenue CAGR with competitors
CASI Pharmaceuticals (CASI) five years revenue CAGR is 6.66%.